SW
BIOA

SVB Wealth’s BioAge Labs BIOA Stock Holding History

SVB Wealth’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-300
Closed -$1.13K – 1682
2025
Q1 		$1.13K Buy
+300
New +$1.39K ﹤0.01% 1336

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

SVB Wealth's BIOA Position: Q2 2025 in Review

SVB Wealth sold out of BioAge Labs (BIOA) in Q2 2025, closing a stake of 300 shares — an estimated $1.13K sold.

SVB Wealth first reported a position in BIOA in Q1 2025 and held it in 1 quarter. The position peaked at $1.13K in Q1 2025. 83 funds tracked by Wall St. Rank hold BIOA as of Q2 2025.

  • SVB Wealth reported no remaining BioAge Labs position as of Q2 2025 after selling out during the quarter.
  • SVB Wealth sold 300 BioAge Labs shares in Q2 2025, an estimated $1.13K.
  • SVB Wealth first reported a position in BioAge Labs in Q1 2025 and held it in 1 quarter.
  • SVB Wealth's BioAge Labs position peaked at $1.13K in Q1 2025.
  • 83 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.